Maternal chronic hypoxia increases expression of genes regulating lung liquid movement and surfactant maturation in male fetuses in late gestation
Author
dc.contributor.author
McGillick, Erin V.
Author
dc.contributor.author
Orgeig, Sandra
Author
dc.contributor.author
Allison, Beth J.
Author
dc.contributor.author
Brain, Kirsty L.
Author
dc.contributor.author
Niu, Youguo
Author
dc.contributor.author
Itani, Nozomi
Author
dc.contributor.author
Skeffington, Katie L.
Author
dc.contributor.author
Kane, Andrew D.
Author
dc.contributor.author
Herrera Videla, Emilio
Author
dc.contributor.author
Giussani, Dino A.
Author
dc.contributor.author
Morrison, Janna L.
Admission date
dc.date.accessioned
2018-05-23T16:21:05Z
Available date
dc.date.available
2018-05-23T16:21:05Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
J Physiol 595.13 (2017) pp 4329–4350
es_ES
Identifier
dc.identifier.other
10.1113/JP273842
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/148072
Abstract
dc.description.abstract
Chronic fetal hypoxaemia is a common pregnancy complication that may arise from maternal, placental and/or fetal factors. Respiratory outcome of the infant at birth likely depends on the duration, timing and severity of the hypoxaemic insult. We have isolated the effect of maternal chronic hypoxia (MCH) for a month in late gestation on fetal lung development. Pregnant ewes were exposed to normoxia (21% O-2) or hypoxia (10% O-2) from 105 to 138days of gestation (term approximate to 145days). At 138days, gene expression in fetal lung tissue was determined by quantitative RT-PCR. Cortisol concentrations were determined in fetal plasma and lung tissue. Numerical density of surfactant protein positive cells was determined by immunohistochemistry. MCH reduced maternal PaO2 (1062.9vs. 472.8mmHg) and fetal body weight (4.00.4vs. 3.20.9kg). MCH increased fetal lung expression of the anti-oxidant marker CAT and decreased expression of the pro-oxidant marker NOX-4. MCH increased expression of genes regulating hypoxia signalling and feedback (HIF-3, KDM3A, SLC2A1, EGLN-3). There was no effect of MCH on fetal plasma/lung tissue cortisol concentrations, nor genes regulating glucocorticoid signalling (HSD11B-1, HSD11B-2, NR3C1, NR3C2). MCH increased expression of genes regulating sodium (SCNN1-B, ATP1-A1, ATP1-B1) and water (AQP-4) movement in the fetal lung. MCH promoted surfactant maturation (SFTP-B, SFTP-D, ABCA3) at the molecular level, but did not alter the numerical density of surfactant positive cells in lung tissue. MCH in late gestation promotes molecular maturation of the fetal lung, which may be an adaptive response in preparation for the successful transition to air-breathing at birth.
es_ES
Patrocinador
dc.description.sponsorship
British Heart Foundation /
National Health and Medical Research Council (NHMRC), APP1030853 /
NHMRC, APP1066916